Welcome to chemicalbook!
Chinese English Japanese Germany Korea
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List Brivaracetam

Brivaracetam synthesis

1synthesis methods
Brivaracetam, also known as UCB 34714, is a chemical analog of levetiracetam, is a racetam derivative with anticonvulsant (antiepileptic) properties approved for the treatment of epilepsy. Brivaracetam was discontinued. Synthetic Description Reference: Qiu S, Tehrani KA, Sergeyev S, Bultinck P, Herrebout W, Mathieu B. Stereochemistry of the Brivaracetam Diastereoisomers. Chirality. 2016 Mar;28(3):215-25. doi: 10.1002/chir.22558. Epub 2016 Jan 6. PubMed PMID: 26740317. Synthetic Description Reference: Huang, Shaozhi; Shi, Lei; Chen, Yiwen; Xu, Yawen. Method for preparing brivaracetam. CN 105646319. (Assignee Foshan Longxin Pharmaceutical Science and Technology Co., Ltd., Peop. Rep. China) Synthetic Description Reference: Wang, Chunyan; Chen, Zhiyong; Wang, Cong. Preparation method of brivaracetam and its intermediate. CN 106748950. (Assignee Chengdu Miracle Pharmaceutical Co., Ltd., Peop. Rep. China) Synthetic Description Reference: Liu, Xingxin; Wu, Liming; Li, Qian; Xiao, Jianyang; Guo, Peng. Synthesis method of brivaracetam from pentanoic acid or pentoyl halide. CN 107216276. (Assignee AstaTech (Chengdu) Biopharmaceutical Co., Ltd., Peop. Rep. China) Synthetic Description Reference: Kenda BM, Matagne AC, Talaga PE, Pasau PM, Differding E, Lallemand BI, Frycia AM, Moureau FG, Klitgaard HV, Gillard MR, Fuks B, Michel P. Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity. J Med Chem. 2004 Jan 29;47(3):530-49. PubMed PMID: 14736235. Synthetic Description Reference: Ates, Celal; Lurquin, Francoise; Quesnel, Yannick; Schule, Arnaud. Preparation of 4-substituted-pyrrolidin-2-ones and their uses for the synthesis of 2-oxo-pyrrolidin-1-yl derivatives. WO 2007031263. (Assignee UCB S. A., Belg.) Synthetic Description Reference: Schule, Arnaud; Merschaert, Alain; Szczepaniak, Christophe; Marechal, Christophe; Carly, Nicolas; O'Rourke, John; Ates, Celal. A Biocatalytic Route to the Novel Antiepileptic Drug Brivaracetam. Organic Process Research & Development. (UCB Pharma S.A.) Synthetic Description Reference: Ates, Celal; Schule, Arnaud. Preparation of 1-carbamoylalkyl-3-carboxy-2-oxopyrrolidines. WO 2007065634. (Assignee UCB Pharma, S. A., Belg.) Synthetic Description Reference: Wang, Peng; Li, Pixu; Wei, Qiang; Liu, Yuanhua. Processes to produce brivaracetam. WO 2016191435. Synthetic Description Reference: Defrance, Thierry; Septavaux, Jean; Nuel, Didier. Process for preparing brivaracetam. WO 2017076738. (Assignee UCB Biopharma Sprl, Belg.) Synthetic Description Reference: Kumar, Pramod; Sankareswaran, Srimurugan; Mannam, Madhavarao; Gaddam, Venugopal Reddy; Chiluukuru, Srikanth; Chaubey, Bipin Kumar. Novel process for the preparation of Brivaracetam. WO 2018042393. (Assignee Micro Labs Limited, India)
Synthetic Routes
  • ROUTE 1
  • 202112070520742619.jpg

    Reference: Qiu S, Tehrani KA, Sergeyev S, Bultinck P, Herrebout W, Mathieu B. Stereochemistry of the Brivaracetam Diastereoisomers. Chirality. 2016 Mar;28(3):215-25. doi: 10.1002/chir.22558. Epub 2016 Jan 6. PubMed PMID: 26740317.

    Ciceri, Samuele; Grisenti, Paride; Elahi, Shahrzad Reza; Ferraboschi, Patrizia. A new chemoenzymatic synthesis of the chiral key intermediate of the antiepileptic brivaracetam. Molecules.Volume 23. Issue 9.Pages 2206/1-2206/11. 2018.

  • ROUTE 2
  • 202112075078753527.jpg

    Reference: Huang, Shaozhi; Shi, Lei; Chen, Yiwen; Xu, Yawen. Method for preparing brivaracetam. CN 105646319. (Assignee Foshan Longxin Pharmaceutical Science and Technology Co., Ltd., Peop. Rep. China)

  • ROUTE 3
  • 202112075304429634.jpg

    Reference: Wang, Chunyan; Chen, Zhiyong; Wang, Cong. Preparation method of brivaracetam and its intermediate. CN 106748950. (Assignee Chengdu Miracle Pharmaceutical Co., Ltd., Peop. Rep. China)

  • ROUTE 4
  • 202112072077670407.jpg

    Reference: Liu, Xingxin; Wu, Liming; Li, Qian; Xiao, Jianyang; Guo, Peng. Synthesis method of brivaracetam from pentanoic acid or pentoyl halide. CN 107216276. (Assignee AstaTech (Chengdu) Biopharmaceutical Co., Ltd., Peop. Rep. China)

  • ROUTE 5
  • 202112073712297562.jpg

    Reference: Kenda BM, Matagne AC, Talaga PE, Pasau PM, Differding E, Lallemand BI, Frycia AM, Moureau FG, Klitgaard HV, Gillard MR, Fuks B, Michel P. Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity. J Med Chem. 2004 Jan 29;47(3):530-49. PubMed PMID: 14736235.

  • ROUTE 6
  • 202112076617972275.jpg

    Reference: Ates, Celal; Lurquin, Francoise; Quesnel, Yannick; Schule, Arnaud. Preparation of 4-substituted-pyrrolidin-2-ones and their uses for the synthesis of 2-oxo-pyrrolidin-1-yl derivatives. WO 2007031263. (Assignee UCB S. A., Belg.)

  • ROUTE 7
  • 202112073649346826.jpg

    Reference: Schule, Arnaud; Merschaert, Alain; Szczepaniak, Christophe; Marechal, Christophe; Carly, Nicolas; O'Rourke, John; Ates, Celal. A Biocatalytic Route to the Novel Antiepileptic Drug Brivaracetam. Organic Process Research & Development. (UCB Pharma S.A.)

  • ROUTE 8
  • 202112071580218956.jpg

    Reference: Ates, Celal; Schule, Arnaud. Preparation of 1-carbamoylalkyl-3-carboxy-2-oxopyrrolidines. WO 2007065634. (Assignee UCB Pharma, S. A., Belg.)

  • ROUTE 9
  • 202112077932439541.jpg

    Reference: Wang, Peng; Li, Pixu; Wei, Qiang; Liu, Yuanhua. Processes to produce brivaracetam. WO 2016191435.

  • ROUTE 10
  • 202112073639642286.jpg

    Reference: Defrance, Thierry; Septavaux, Jean; Nuel, Didier. Process for preparing brivaracetam. WO 2017076738. (Assignee UCB Biopharma Sprl, Belg.)

  • ROUTE 11
  • 202112076987918990.jpg

    Reference: Kumar, Pramod; Sankareswaran, Srimurugan; Mannam, Madhavarao; Gaddam, Venugopal Reddy; Chiluukuru, Srikanth; Chaubey, Bipin Kumar. Novel process for the preparation of Brivaracetam. WO 2018042393. (Assignee Micro Labs Limited, India)

  • ROUTE 12
  • 202112072345682732.jpg

    Ciceri, Samuele; Grisenti, Paride; Elahi, Shahrzad Reza; Ferraboschi, Patrizia. A new chemoenzymatic synthesis of the chiral key intermediate of the antiepileptic brivaracetam. Molecules.Volume 23. Issue 9.Pages 2206/1-2206/11. 2018.

202112070520742619.jpg

Reference: Qiu S, Tehrani KA, Sergeyev S, Bultinck P, Herrebout W, Mathieu B. Stereochemistry of the Brivaracetam Diastereoisomers. Chirality. 2016 Mar;28(3):215-25. doi: 10.1002/chir.22558. Epub 2016 Jan 6. PubMed PMID: 26740317.

Ciceri, Samuele; Grisenti, Paride; Elahi, Shahrzad Reza; Ferraboschi, Patrizia. A new chemoenzymatic synthesis of the chiral key intermediate of the antiepileptic brivaracetam. Molecules.Volume 23. Issue 9.Pages 2206/1-2206/11. 2018.

357338-13-7 Synthesis
(S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide

357338-13-7
37 suppliers
inquiry

-

Yield:357336-20-0 99.3%

Reaction Conditions:

with (R)-(-)-5,5'-bis[di(3,5-ditert-butyl-4-methoxyphenyl)phosphino]-4,4'-bi-1,3-benzodioxole;copper chloride (I);sodium tertiary butoxide in toluene at -40; for 24 h;Inert atmosphere;

Steps:

1

(2S) -2- ((4R) -2-oxo-4-n-propyl-1-pyrrolidinyl) butanamide,Which comprises the following steps: adding 430 mg of cuprous chloride, 420 mg of sodium tert-butoxide, 120 mg of (R) -DTBM-SEGPH0S to the reaction vessel under the protection of nitrogen And 240 ml of toluene, stirred for 20 min; then the temperature was adjusted to -40 ° C, 60 g of the starting material was added,(2S) - (2-oxo-4-propyl-2,5-dihydro-1-pyrrolyl) butanamide; and the reaction mixture was added 40 ml of polymethylhydrogensiloxane (S0 0.67 mil of polymethylhydrogensiloxane) and then incubated at a temperature of -40 ° C After 24 hours of reaction, the temperature was adjusted to 0 ° C, then 100 ml of saturated sodium bicarbonate solution and 150 ml of ether were added, And then stirring l0h; then, the use of ether on the reaction material extraction 2 times, combined with 2 extracted organic layer, and then there will beThe machine bed is dried, filtered, concentrated to obtain the product. 58 g of crude product was weighed and then recrystallized using isopropyl ether, 49 g of product was obtained, and the product after recrystallization was detected by high performance liquid chromatography. The detection conditions were: 0D-HColumn, n-hexane: isopropanol (90:10) as mobile phase, tassel is 1.01111 / 1 ^ 11, detection wavelength is 210 brain, detected by 4(R) type chiral material (i.e., (2S) -2- ((4R) -2-oxo-4-n-propyl-1-pyrrolidinyl) butanamide) 99.3%.

References:

CN104892483,2017,B Location in patent:Paragraph 0029-0030

Brivaracetam Related Search: